tiprankstipranks
Organo Corp. (JP:6368)
:6368
Japanese Market
Want to see JP:6368 full AI Analyst Report?

Organo Corp. (6368) AI Stock Analysis

1 Followers

Top Page

JP:6368

Organo Corp.

(6368)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 5.2)
Rating:73Outperform
Price Target:
¥18,253.00
▲(20.56% Upside)
Action:Upgraded
Date:05/15/26
The score is driven primarily by strong financial performance, highlighted by sustained revenue growth and significant margin expansion, tempered by rising debt and historically uneven cash-flow consistency. Technically, the stock is in a strong uptrend but appears overbought, and valuation support is only moderate with a ~22 P/E and ~1% dividend yield.
Positive Factors
Margin Expansion
Sustained expansion in gross and net margins reflects structural improvements in pricing, product mix and cost control. Higher margins increase cash conversion and resilience to cyclical revenue swings, supporting durable profitability and reinvestment capacity over the next several quarters.
Negative Factors
Rising Debt
The notable uptick in total debt raises rollover and interest-rate risk if earnings or cash flow weaken. Continued reliance on borrowings would increase fixed obligations and could constrain strategic flexibility unless matched by sustained cash generation over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Margin Expansion
Sustained expansion in gross and net margins reflects structural improvements in pricing, product mix and cost control. Higher margins increase cash conversion and resilience to cyclical revenue swings, supporting durable profitability and reinvestment capacity over the next several quarters.
Read all positive factors

Organo Corp. (6368) vs. iShares MSCI Japan ETF (EWJ)

Organo Corp. Business Overview & Revenue Model

Company Description
Organo Corporation, a Tokyo-headquartered enterprise established in 1941 (and known as Japan Organo Co., Ltd. until its name change in 1966), is a global specialist in water treatment engineering. The company's business activities are structured i...
How the Company Makes Money
null...

Organo Corp. Financial Statement Overview

Summary
Strong multi-year revenue growth and material margin expansion (gross margin ~26% to ~36.6%; net margin ~7% to ~16%) support a high score. Constraints are the notable rise in debt from 2025 to 2026 and historically volatile operating/free cash flow despite strong recent cash generation.
Income Statement
86
Very Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
BreakdownTTMMar 2026Mar 2026Mar 2025Mar 2024Mar 2023
Income Statement
Total Revenue169.76B177.65B163.27B150.36B132.43B112.07B
Gross Profit58.45B65.08B55.18B43.84B34.98B28.51B
EBITDA36.69B40.59B34.53B25.88B18.02B14.15B
Net Income25.12B28.40B24.15B17.31B11.73B9.21B
Balance Sheet
Total Assets190.39B224.87B194.40B182.70B164.85B130.51B
Cash, Cash Equivalents and Short-Term Investments20.57B31.05B16.75B17.64B15.56B20.20B
Total Debt28.15B34.40B22.73B36.67B33.25B15.87B
Total Liabilities71.01B81.90B73.20B80.55B78.48B54.50B
Stockholders Equity119.38B142.96B120.95B101.93B86.17B75.84B
Cash Flow
Free Cash Flow0.0029.37B26.54B20.50B-21.18B8.29B
Operating Cash Flow0.0031.44B28.80B21.69B-19.98B10.79B
Investing Cash Flow0.00-2.74B-2.13B-1.42B-1.31B-1.52B
Financing Cash Flow0.003.12B-20.82B-641.00M14.71B-2.59B

Organo Corp. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price15140.00
Price Trends
50DMA
16352.70
Positive
100DMA
15867.73
Positive
200DMA
14363.13
Positive
Market Momentum
MACD
239.17
Negative
RSI
49.70
Neutral
STOCH
33.27
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6368, the sentiment is Positive. The current price of 15140 is below the 20-day moving average (MA) of 16089.25, below the 50-day MA of 16352.70, and above the 200-day MA of 14363.13, indicating a bullish trend. The MACD of 239.17 indicates Negative momentum. The RSI at 49.70 is Neutral, neither overbought nor oversold. The STOCH value of 33.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6368.

Organo Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥1.02T62.446.61%1.58%-1.47%-19.80%
75
Outperform
¥269.98B19.699.02%3.11%9.57%40.16%
74
Outperform
¥89.76B11.5616.37%2.79%42.29%54.99%
73
Outperform
¥751.20B26.501.43%8.81%17.58%
64
Neutral
¥155.87B17.0612.54%1.84%17.17%33.29%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
59
Neutral
¥212.35B19.032.41%5.68%-49.64%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6368
Organo Corp.
16,370.00
7,502.01
84.60%
JP:6370
Kurita Water Industries
9,080.00
3,485.51
62.30%
JP:9551
METAWATER Co
3,570.00
1,398.80
64.42%
JP:6013
Takuma Co
3,650.00
1,671.26
84.46%
JP:6331
Mitsubishi Kakoki Kaisha,Ltd.
3,830.00
1,888.74
97.29%
JP:7004
Hitachi Zosen Corporation
1,260.00
308.55
32.43%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 15, 2026